Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osamu Morimura

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Internal Medicine (Tokyo, Japan)|April 3, 2012
Prognostic factors in malignant pleural mesothelioma: a retrospective studyHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 20, 2012
Impact of pneumonia on hyperactive delirium in end-stage lung cancer patientsHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2019
A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102Takashi Yokoi, Seigo Minami, Takayuki Shiroyama, et al.
Molecular and Clinical Oncology|March 21, 2014
Carboplatin plus paclitaxel in combination with bevacizumab for the treatment of adenocarcinoma with interstitial lung diseasesHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
FEBS Letters|October 8, 2016
Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas databaseMasayoshi Higashiguchi, Izumi Nagatomo, Takashi Kijima, et al.
Clinical Lung Cancer|May 22, 2012
Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancerMotohiro Tamiya, Masashi Kobayashi, Osamu Morimura, et al.
Scandinavian Journal of Gastroenterology|April 28, 2023
Gastrointestinal symptoms in 609 Japanese patients with COVID-19: a single-center retrospective studyShinji Kuriki, Tsutomu Nishida, Li-Sa Chang, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2015
Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluidYuhei Kinehara, Takashi Kijima, Koji Inoue, et al.
JTO Clinical and Research Reports|November 29, 2023
Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLCYuhei Kinehara, Takayuki Shiroyama, Akihiro Tamiya, et al.
JTO Clinical and Research Reports|June 7, 2023
Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLCTomoki Kuge, Takayuki Shiroyama, Akihiro Tamiya, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Internal Medicine (Tokyo, Japan)|April 3, 2012
Prognostic factors in malignant pleural mesothelioma: a retrospective studyHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 20, 2012
Impact of pneumonia on hyperactive delirium in end-stage lung cancer patientsHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2019
A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102Takashi Yokoi, Seigo Minami, Takayuki Shiroyama, et al.
Molecular and Clinical Oncology|March 21, 2014
Carboplatin plus paclitaxel in combination with bevacizumab for the treatment of adenocarcinoma with interstitial lung diseasesHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
FEBS Letters|October 8, 2016
Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas databaseMasayoshi Higashiguchi, Izumi Nagatomo, Takashi Kijima, et al.
Clinical Lung Cancer|May 22, 2012
Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancerMotohiro Tamiya, Masashi Kobayashi, Osamu Morimura, et al.
Scandinavian Journal of Gastroenterology|April 28, 2023
Gastrointestinal symptoms in 609 Japanese patients with COVID-19: a single-center retrospective studyShinji Kuriki, Tsutomu Nishida, Li-Sa Chang, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2015
Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluidYuhei Kinehara, Takashi Kijima, Koji Inoue, et al.
JTO Clinical and Research Reports|November 29, 2023
Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLCYuhei Kinehara, Takayuki Shiroyama, Akihiro Tamiya, et al.
JTO Clinical and Research Reports|June 7, 2023
Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLCTomoki Kuge, Takayuki Shiroyama, Akihiro Tamiya, et al.
Pageof 4